Publications by authors named "John Grabenstein"

Claim this Profile
P
Pharmacists' answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States.
Roua El Kalach, Nkenge H Jones-Jack, John D Grabenstein, Mattie Elam, Abdulhakeem A Olorukooba

J Am Pharm Assoc (2003)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines against mpox: MVA-BN and LC16m8.
John D Grabenstein, Adam Hacker

Expert Rev Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidence.
Benjamin M Bluml, Scott A Hamstra, Lisa L Tonrey, Jonathan B Little, Aaron J Bonham, John D Grabenstein

J Am Pharm Assoc (2003)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women in pharmacy: Pearls of wisdom from the 2022 inductees and contemporary leaders.
Jennifer M Bingham, John D Grabenstein

J Am Pharm Assoc (2003)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global geotemporal distribution of chikungunya disease, 2011-2022.
John D Grabenstein, Aditya Singh Tomar

Travel Med Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy on the front lines: A century of pandemic response in America.
Jennifer M Bingham, John D Grabenstein, Sandra Leal, David R Axon

J Am Pharm Assoc (2003)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine.
John D Grabenstein, Pietro Ferrara, Lorenzo G Mantovani, Ian McGovern

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an Innovative Immunization Practice Model to Improve Population Health: Results of the Project IMPACT Immunizations Scaled Demonstration.
Benjamin M Bluml, Kelly A Brock, William R Doucette, John D Grabenstein, Nicole Scovis

Innov Pharm· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions.
John D Grabenstein

J Am Pharm Assoc (2003)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine humanity.
John D Grabenstein

J Am Pharm Assoc (2003)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remington Honor Medal Address.
John D Grabenstein

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answering Key Questions About COVID-19 Vaccines.
Jesse L Goodman, John D Grabenstein, M Miles Braun

JAMA· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting.
Fiona Ecarnot, Gaetano Crepaldi, Philippe Juvin, John Grabenstein, Giuseppe Del Giudice

BMC Public Health· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
outbreaks and implications for transmission and control: a systematic review.
Paul N Zivich, John D Grabenstein, Sylvia I Becker-Dreps, David J Weber

Pneumonia (Nathan)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of adult community-acquired pneumonia cases attributable to Streptococcus pneumoniae among Hajj pilgrims in 2016.
Ali AlBarrak, Badriah Alotaibi, Yara Yassin, Abdulaziz Mushi, Fuad Maashi, John Grabenstein

Int J Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.
Karen L Ciprero, Rocio D Marchese, Patrick Richard, Martine Baudin, Tina M Sterling, John D Grabenstein

Hum Vaccin Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the Numbers of US Colleges of Pharmacy and Their Graduates, 1900 to 2014.
John D Grabenstein

Am J Pharm Educ· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ebola virus disease.
Paul E Kilgore, John D Grabenstein, Abdulbaset M Salim, Michael Rybak

Pharmacotherapy· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interwoven support: an historical survey of US federal programs enabling immunization.
Dack W Dalrymple, John D Grabenstein

Vaccine· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults.
John D Grabenstein, Luwy K Musey

Vaccine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pneumococcal vaccines for adults in the United States.
Jieling Chen, Megan A O'Brien, H Keri Yang, John D Grabenstein, Erik J Dasbach

Adv Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake.
John D Grabenstein, David J Weber

Clin Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What the world's religions teach, applied to vaccines and immune globulins.
John D Grabenstein

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44.
John D Grabenstein, Megan A O'Brien, Jieling Chen

Vaccine· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults.
John D Grabenstein, Susan B Manoff

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis